Live Breaking News & Updates on Atharva karulkar

Stay informed with the latest breaking news from Atharva karulkar on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Atharva karulkar and stay connected to the pulse of your community

Crafted in Indian labs, NexCAR19 takes India to next level in cancer care

Crafted in Indian labs, NexCAR19 takes India to next level in cancer care
thehindu.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindu.com Daily Mail and Mail on Sunday newspapers.

India , Maryland , United-states , Bombay , Maharashtra , Hyderabad , Andhra-pradesh , National-institutes-of-health , Mumbai , American , Hasmukh-jain , Alka-dwivedi

Crafted in Indian labs, NexCAR19 takes India to next level in cancer care

Crafted in Indian labs, NexCAR19 takes India to next level in cancer care
thehindu.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindu.com Daily Mail and Mail on Sunday newspapers.

India , United-states , Maryland , Bombay , Maharashtra , Mumbai , American , Atharva-karulkar , Gaurav-narula , Rahul-purwar , Nirali-shah , Shirish-arya

1st indigenously developed cancer cell therapy unveiled at IIT Bombay

1st indigenously developed cancer cell therapy unveiled at IIT Bombay
tribuneindia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tribuneindia.com Daily Mail and Mail on Sunday newspapers.

Bombay , Maharashtra , India , New-delhi , Delhi , Atharva-karulkar , Alka-dwivedi , Rahul-purwar , Tribune-news-service , Droupadi-murmu , Tata-memorial-hospital , Prof-rahul-purwar

President Murmu Launches India's First 'Home-Grown Gene Therapy' For Cancer at IIT Bombay

India’s first CAR-T cell therapy, NexCAR19, is developed through collaboration between the IIT Bombay and Tata Memorial Hospital, in association with industry partner ImmunoACT, a start-up of two students Alka Dwivedi and Atharva Karulkar, and professor Rahul Purwar. TheHealthSite.com

India , Bombay , Maharashtra , Atmanirbhar-bharat , Droupadi-murmu , Alka-dwivedi , Chanchal-sharma , Atharva-karulkar , Rahul-purwar , Indian-institute-of-technology , President-murmu-launches-india , Home-grown-gene-therapy-for-cancer

President Murmu launches India's 1st home-grown gene therapy for cancer

President Murmu launches India's 1st home-grown gene therapy for cancer
nagpurtoday.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nagpurtoday.in Daily Mail and Mail on Sunday newspapers.

Bombay , Maharashtra , India , Alka-dwivedi , Droupadi-murmu , Rahul-purwar , Atharva-karulkar , Indian-institute-of-technology , Indian-institute , Tata-memorial-hospital , Professor-rahul-purwar ,

NexCAR 19 cancer therapy: Conceived at IIT Bombay, delivered in Tata Memorial

CAR T-cell therapy involves modifying a patient’s T-cells—white blood cells that are integral to the immune system. The lab-modified cells are then infused in the patient to multiply and fight cancerous cells. The therapy costs $400,000 in the US and tenth of that in India. But, does it work?

Mirzapur , Uttar-pradesh , India , Madrid , Spain , Bombay , Maharashtra , Mumbai , Germany , Faridabad , Haryana , United-states

ImmunoACT gets CDSCO approval for India's first CAR-T cell therapy for blood cancer

ImmunoACT intends to make the NexCAR19 (Actaly cabtagene autoleucel) therapy available to its partner hospitals as soon as possible

India , Bombay , Maharashtra , Gaurav-narula , Rahul-purwar , Atharva-karulkar , Hasmukh-jain , Alka-dwivedi , Tata-memorial-centre , Society-for-innovation , Central-drugs-standard-control-organization , Immunoadoptive-cell-therapy-private-limited-immuno

IIT-B startup ImmunoACT's "affordable" blood cancer therapy gets regulatory approval - a first for India's CAR-T cell therapy

India Business News: The Indian drug regulator has granted approval to ImmunoACT for its CAR-T cell therapy NexCAR19, designed to treat certain types of blood cancers. The

Bombay , Maharashtra , India , Hyderabad , Andhra-pradesh , Piyush-goyal , Hasmukh-jain , Gaurav-narula , Alka-dwivedi , Atharva-karulkar , Rahul-purwar , Central-drugs-standard-control-organization

ImmunoACT announces the approval of India's first CAR-T cell therapy, NexCAR19

ImmunoACT announces the approval of India's first CAR-T cell therapy, NexCAR19
equitybulls.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from equitybulls.com Daily Mail and Mail on Sunday newspapers.

India , Bombay , Maharashtra , Mumbai , Shirish-arya , Satyanarayana-chava , Hasmukh-jain , Gaurav-narula , Atharva-karulkar , Rahul-purwar , Alka-dwivedi , Society-for-innovation

Blood cancer trust: CDSCO approves India's first CAR-T cell therapy against certain blood cancers

Indian company ImmunoACT, backed by drug maker Laurus Labs, has received approval from the Central Drugs Standard Control Organization for its CAR-T cell therapy NexCAR19. The therapy is the first of its kind to be developed in India and will be used to treat certain types of blood cancers. ImmunoACT intends to make the drug available to partner hospitals as soon as possible.

Kozhikode , Kerala , India , Hyderabad , Andhra-pradesh , Bombay , Maharashtra , Atharva-karulkar , Alka-dwivedi , Rahul-purwar , Hasmukh-jain , Gaurav-narula